Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relevance of residual tricuspid regurgitation for right ventricular reverse remodelling after tricuspid valve intervention in patients with severe tricuspid regurgitation and right-sided heart failure.
Weckbach LT, Stolz L, Doldi PM, Glaser H, Ennin C, Kothieringer M, Stocker TJ, Näbauer M, Kassar M, Bombace S, Kresoja KP, Lurz P, Praz F, Thiele H, Rudolph V, Massberg S, Hausleiter J. Weckbach LT, et al. Among authors: bombace s. Eur J Heart Fail. 2024 Nov 26. doi: 10.1002/ejhf.3529. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39592914
Mitral annulus disjunction in consecutive patients undergoing cardiovascular magnetic resonance: Where is the boundary between normality and disease?
Figliozzi S, Stankowski K, Tondi L, Catapano F, Gitto M, Lisi C, Bombace S, Olivieri M, Cannata F, Fazzari F, Bragato RM, Georgiopoulos G, Masci PG, Monti L, Condorelli G, Francone M. Figliozzi S, et al. Among authors: bombace s. J Cardiovasc Magn Reson. 2024 Jul 4;26(2):101056. doi: 10.1016/j.jocmr.2024.101056. Online ahead of print. J Cardiovasc Magn Reson. 2024. PMID: 38971502 Free PMC article.
Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction.
Kresoja KP, Rosch S, Schöber AR, Fengler K, Schlotter F, Bombace S, Sagmeister P, von Roeder M, Kister T, Gutberlet M, Thiele H, Rommel KP, Lurz P. Kresoja KP, et al. Among authors: bombace s. Eur J Heart Fail. 2024 Apr;26(4):1025-1035. doi: 10.1002/ejhf.3195. Epub 2024 Mar 11. Eur J Heart Fail. 2024. PMID: 38462987 Clinical Trial.
Applying the TRILUMINATE Eligibility Criteria to Real-World Patients Receiving Tricuspid Valve Transcatheter Edge-to-Edge Repair.
Stolz L, Doldi PM, Kresoja KP, Bombace S, Koell B, Kassar M, Kirchner J, Weckbach LT, Ludwig S, Stocker TJ, Glaser H, Schöber AR, Massberg S, Näbauer M, Rudolph V, Kalbacher D, Praz F, Lurz P, Hausleiter J. Stolz L, et al. Among authors: bombace s. JACC Cardiovasc Interv. 2024 Feb 26;17(4):535-548. doi: 10.1016/j.jcin.2023.11.014. Epub 2023 Nov 20. JACC Cardiovasc Interv. 2024. PMID: 37987997
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction.
Cremonesi M, Felicetta A, Cannata F, Serio S, van Beek JJP, Bombace S, My I, Zanon V, Catalano C, Papadopoulou V, Monti L, Chiarito M, Stefanini G, Panico C, Francone M, Lugli E, Kallikourdis M, Condorelli G. Cremonesi M, et al. Among authors: bombace s. Circulation. 2023 Aug 8;148(6):504-507. doi: 10.1161/CIRCULATIONAHA.122.062672. Epub 2023 Aug 7. Circulation. 2023. PMID: 37549204 No abstract available.
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design.
Cannata F, Stefanini G, Carlo-Stella C, Chiarito M, Figliozzi S, Novelli L, Lisi C, Bombace S, Panico C, Cosco F, Corrado F, Masci G, Mazza R, Ricci F, Monti L, Ferrante G, Santoro A, Francone M, da Costa BR, Jüni P, Condorelli G. Cannata F, et al. Among authors: bombace s. J Cardiovasc Med (Hagerstown). 2023 Jul 1;24(7):469-474. doi: 10.2459/JCM.0000000000001491. J Cardiovasc Med (Hagerstown). 2023. PMID: 37285278 Clinical Trial.
22 results